Below are the most recent publications written about "Osteosarcoma" by people in Profiles.
-
Doyle M, Dikdan S, Farzad D, Marhefka GD. Three, dynamic variants of ST segment elevations in a patient with osteosarcoma and cardiac metastasis. J Electrocardiol. 2023 May-Jun; 78:29-33.
-
de la Guardia V, O'Meally AA, Gambarotti M, Spinnato P, Frisoni T, Cocchi S, Magagnoli G, Ibrahim T, Benini S, Pacheco M, Righi A. Osteogenic sarcomas of the hands: A case series with emphasis in its peculiarities and literature review. Pathol Res Pract. 2023 Feb; 242:154326.
-
Celik B, Cicek K, Leal AF, Tomatsu S. Regulation of Molecular Targets in Osteosarcoma Treatment. Int J Mol Sci. 2022 Oct 20; 23(20).
-
Averill LW. CORR Insights?: How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma? Clin Orthop Relat Res. 2021 02 01; 479(2):309-311.
-
Iwai T, Oebisu N, Hoshi M, Orita K, Yamamoto A, Hamamoto S, Kageyama K, Nakamura H. Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model. Sci Rep. 2020 06 15; 10(1):9679.
-
Piazzi M, Bavelloni A, Greco S, Focaccia E, Orsini A, Benini S, Gambarotti M, Faenza I, Blalock WL. Expression of the double-stranded RNA-dependent kinase PKR influences osteosarcoma attachment independent growth, migration, and invasion. J Cell Physiol. 2020 02; 235(2):1103-1119.
-
Currier AW, Kolb EA, Gorlick RG, Roth ME, Gopalakrishnan V, Sampson VB. p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma. Sci Rep. 2019 04 16; 9(1):6161.
-
Gennaro VJ, Wedegaertner H, McMahon SB. Interaction between the BAG1S isoform and HSP70 mediates the stability of anti-apoptotic proteins and the survival of osteosarcoma cells expressing oncogenic MYC. BMC Cancer. 2019 Mar 22; 19(1):258.
-
Olivos DJ, Perrien DS, Hooker A, Cheng YH, Fuchs RK, Hong JM, Bruzzaniti A, Chun K, Eischen CM, Kacena MA, Mayo LD. The proto-oncogene function of Mdm2 in bone. J Cell Biochem. 2018 11; 119(11):8830-8840.
-
Bu Y, Yoshida A, Chitnis N, Altman BJ, Tameire F, Oran A, Gennaro V, Armeson KE, McMahon SB, Wertheim GB, Dang CV, Ruggero D, Koumenis C, Fuchs SY, Diehl JA. A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nat Cell Biol. 2018 01; 20(1):104-115.